Apr
24
FDA Approves Novel Medicine, Noxafil, To Prevent Invasive Fungal Infections
April 24, 2008 | Leave a Comment
The U.S. Food and Drug Administration today conceded Noxafil (posaconazole) to shun fungal infection cause by means of spotless molds and yeast-like fungus call Aspergillus and Candida. FDA approved the remedy contained by reinforcement of operation in patients who singular feeble immune system successive wash marrow transplant and for patients beside a standard [...]
Apr
24
ASHP To Joint Commission: Pharmacists’ Role In Infection Control Should Be More Visible
April 24, 2008 | Leave a Comment
The mice were divided into two group haphazardly. In group I, bone defects were complete with Cbfa1-GAM with a dose of 1.2 mg plasmid Cbfa1 DNA per wound. Control sponge in group II were comprise of biodegradable, biocompatible collagen wanting plasmid DNA. Animals were euthanized at 7 and 14 days after the transplantation. [...]
